Hundertmark, M., Agbaje, O., Coleman, R., George, J., Grempler, R., Holman, R., . . . Neubauer, S. (2021). Design and rationale of the EMPA-VISION trial: Investigating the metabolic effects of empagliflozin in patients with heart failure. Wiley Open Access.
Chicago-viite (17. p.)Hundertmark, MJ, et al. Design and Rationale of the EMPA-VISION Trial: Investigating the Metabolic Effects of Empagliflozin in Patients with Heart Failure. Wiley Open Access, 2021.
MLA-viite (9. p.)Hundertmark, MJ, et al. Design and Rationale of the EMPA-VISION Trial: Investigating the Metabolic Effects of Empagliflozin in Patients with Heart Failure. Wiley Open Access, 2021.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.